Decreased Expression of the High Mobility Group Box 1 (HMGB1) Gene in Peripheral Blood in Patients with Mild or Moderate Clostridioides difficile Infection
Open Access
- 11 August 2020
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 8 (8) , 1217
Abstract
Cytokines are mediators of inflammation induced in the course of Clostridioides difficile infection (CDI). High Mobility Group Box 1 (HMGB1) is a cytokine playing an important role in the pathogenesis of numerous inflammatory and autoimmune diseases. The aim of the study was to assess the HMGB1 gene expression in the course of CDI. We have performed a prospective case-control study- including 55 adult patients, among them 27 with CDI, who were hospitalized from October 2018 to February 2020 and 28 healthy volunteers. We assessed: a complete blood count with differential leukocyte count, blood creatinine, albumin, and C-reactive protein (CRP) levels. Then, the expression of the HMGB1 gene was evaluated using quantitative Real-Time PCR. Patients with CDI were found to have a significant increase in white blood cells (WBC), neutrophil count, and CRP levels, they also exhibited decreased levels of albumin compared with controls. The HMGB1 gene expression was significantly lower among patients with CDI compared with the control group and significantly, inversely correlated with CRP level in blood. In conclusion, we have observed a decreased expression of the HMGB1 gene in peripheral blood of patients with mild or moderate CDI, which hypothetically could reflect their diminished capability to fight the pathogen.Keywords
Funding Information
- Grant of the Polish Ministry of National Education (N41/DBS/000284)
This publication has 51 references indexed in Scilit:
- High levels of circulating HMGB1 as a biomarker of acute liver failure in patients with viral hepatitis ELiver International, 2013
- Correction: Clostridium difficile Toxin B Causes Epithelial Cell Necrosis through an Autoprocessing-Independent MechanismPLOS Pathogens, 2012
- Stepwise Release of Biologically Active HMGB1 during HSV-2 InfectionPLOS ONE, 2011
- A Common Polymorphism in the Interleukin‐8 Gene Promoter Is Associated with an Increased Risk for RecurrentClostridium difficileInfectionClinical Infectious Diseases, 2010
- High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-κB and Egr-1Thrombosis and Haemostasis, 2009
- High-Mobility Group Box Proteins Modulate Tumor Necrosis Factor-α Expression in Osteoclastogenesis via a Novel Deoxyribonucleic Acid SequenceMolecular Endocrinology, 2008
- The genetic variation of the human HMGB1 geneTissue Antigens, 2007
- A novel pathway of HMGB1‐mediated inflammatory cell recruitment that requires Mac‐1‐integrinThe EMBO Journal, 2007
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Regulation of monocyte migration by amphoterin (HMGB1)Blood, 2004